Skip to Main Content

Paper Details

Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Res Sq
0
2023
Alum, CD4, CD4 T cells, COVID, COVID-19, Rs, SARS, SARS-CoV-2, SARS-related coronavirus, SHC014, VAERD, aluminum hydroxide, coronavirus-, human, iCoV2, mouse, pulmonary eosinophilic, recombinant Spike protein, vaccine-associated enhanced respiratory disease
Author NameAffiliation
Mark T HeiseUniversity of North Carolina at Chapel Hill.
Mark T HeiseUniversity of North Carolina at Chapel Hill.
Sarah R LeistUniversity of North Carolina at Chapel Hill.
Boyd L YountGillings School of Public Health, University of North Carolina at Chapel Hill.
Martin T FerrisUniversity of North Carolina.
Martin T FerrisUniversity of North Carolina.
Ralph S BaricUniversity of North Carolina at Chapel Hill.
Ralph S BaricUniversity of North Carolina at Chapel Hill.
  • 1 - 8

Datasets

Release 1.2